39378208|t|Effect of ACE mutations on blood ACE phenotype parameters.
39378208|a|BACKGROUND: Analysis of existing mutations of Angiotensin-I-Converting Enzyme (ACE) led us to hypothesize that the carriers of damaging ACE mutations (accompanied by low ACE levels) could be at risk for the development of late-onset Alzheimer's disease (AD). METHODOLOGY/PRINCIPAL FINDINGS: We quantified blood ACE levels in EDTA-containing plasma from 15 patients with 11 different heterozygous ACE mutations and estimated the effects of these mutations on ACE phenotypes, using a set of mAbs to ACE and two ACE substrates. We confirmed prior observations that the relatively frequent Y215C mutation in the N domain of ACE (present in ~1% of the population) is associated with both Alzheimer's disease (AD) and reduced plasma levels of ACE (~50% of controls), indicating that it likely results in a transport-deficient protein. In addition, we identified another 4 mutations in both ACE domains (M118T, C734Y, V992M and V997M) which are also associated with decreased ACE levels in the blood, and, thus, could be putative risk factors for late-onset AD. One of these mutations, C734Y, is likely transport-deficient, while the other mutations appear to influence ACE catalytic properties. The precipitation of mutant M118T by mAb 2D1 and ACE mutant C734Y by mAb 3F10 increased 2-3-fold compared to native ACE, and therefore, these mAbs could be markers of these mutations. Also, we identified a mutation I989T, which is associated with increased ACE levels in the blood. CONCLUSIONS/SIGNIFICANCE: Conducting a systematic analysis of blood ACE levels in patients with ACE mutations holds promise for identifying individuals with low blood ACE levels. Such individuals may be at increased risk for late-onset AD. The patients with transport-deficient ACE mutations may benefit from therapeutic treatment with a combination of chemical and pharmacological chaperones and proteasome inhibitors, as was demonstrated previously using a cell model of the transport-deficient ACE mutation, Q1069R [Danilov et al, PLoS One, 2010].
39378208	10	13	ACE	Gene	1636
39378208	33	36	ACE	Gene	1636
39378208	105	136	Angiotensin-I-Converting Enzyme	Gene	1636
39378208	138	141	ACE	Gene	1636
39378208	195	198	ACE	Gene	1636
39378208	229	232	ACE	Gene	1636
39378208	292	311	Alzheimer's disease	Disease	MESH:D000544
39378208	313	315	AD	Disease	MESH:D000544
39378208	370	373	ACE	Gene	1636
39378208	384	388	EDTA	Chemical	MESH:D004492
39378208	415	423	patients	Species	9606
39378208	455	458	ACE	Gene	1636
39378208	517	520	ACE	Gene	1636
39378208	556	559	ACE	Gene	1636
39378208	568	571	ACE	Gene	1636
39378208	645	650	Y215C	ProteinMutation	tmVar:p|SUB|Y|215|C;HGVS:p.Y215C;VariantGroup:1;CorrespondingGene:1636;CorrespondingSpecies:9606
39378208	679	682	ACE	Gene	1636
39378208	742	761	Alzheimer's disease	Disease	MESH:D000544
39378208	763	765	AD	Disease	MESH:D000544
39378208	796	799	ACE	Gene	1636
39378208	943	946	ACE	Gene	1636
39378208	956	961	M118T	ProteinMutation	tmVar:p|SUB|M|118|T;HGVS:p.M118T;VariantGroup:5;CorrespondingGene:1636;CorrespondingSpecies:9606
39378208	963	968	C734Y	ProteinMutation	tmVar:p|SUB|C|734|Y;HGVS:p.C734Y;VariantGroup:4;CorrespondingGene:1636;CorrespondingSpecies:9606
39378208	970	975	V992M	ProteinMutation	tmVar:p|SUB|V|992|M;HGVS:p.V992M;VariantGroup:6;CorrespondingGene:1636;CorrespondingSpecies:9606
39378208	980	985	V997M	ProteinMutation	tmVar:p|SUB|V|997|M;HGVS:p.V997M;VariantGroup:0;CorrespondingGene:1636;RS#:745486055;CorrespondingSpecies:9606;CA#:8700338
39378208	1028	1031	ACE	Gene	1636
39378208	1110	1112	AD	Disease	MESH:D000544
39378208	1138	1143	C734Y	ProteinMutation	tmVar:p|SUB|C|734|Y;HGVS:p.C734Y;VariantGroup:4;CorrespondingGene:1636;CorrespondingSpecies:9606
39378208	1222	1225	ACE	Gene	1636
39378208	1276	1281	M118T	ProteinMutation	tmVar:p|SUB|M|118|T;HGVS:p.M118T;VariantGroup:5;CorrespondingGene:1636;CorrespondingSpecies:9606
39378208	1297	1300	ACE	Gene	1636
39378208	1308	1313	C734Y	ProteinMutation	tmVar:p|SUB|C|734|Y;HGVS:p.C734Y;VariantGroup:4;CorrespondingGene:1636;CorrespondingSpecies:9606
39378208	1364	1367	ACE	Gene	1636
39378208	1463	1468	I989T	ProteinMutation	tmVar:p|SUB|I|989|T;HGVS:p.I989T;VariantGroup:3;CorrespondingGene:1636;CorrespondingSpecies:9606
39378208	1505	1508	ACE	Gene	1636
39378208	1598	1601	ACE	Gene	1636
39378208	1612	1620	patients	Species	9606
39378208	1626	1629	ACE	Gene	1636
39378208	1697	1700	ACE	Gene	1636
39378208	1766	1768	AD	Disease	MESH:D000544
39378208	1774	1782	patients	Species	9606
39378208	1808	1811	ACE	Gene	1636
39378208	2027	2030	ACE	Gene	1636
39378208	2041	2047	Q1069R	ProteinMutation	tmVar:p|SUB|Q|1069|R;HGVS:p.Q1069R;VariantGroup:2;CorrespondingGene:1636;CorrespondingSpecies:9606
39378208	Positive_Correlation	MESH:D000544	HGVS:p.Y215C;CorrespondingGene:1636
39378208	Positive_Correlation	MESH:D000544	RS#:745486055;HGVS:p.V997M;CorrespondingGene:1636
39378208	Positive_Correlation	MESH:D000544	HGVS:p.M118T;CorrespondingGene:1636
39378208	Positive_Correlation	MESH:D000544	HGVS:p.V992M;CorrespondingGene:1636
39378208	Positive_Correlation	MESH:D000544	HGVS:p.C734Y;CorrespondingGene:1636
39378208	Association	MESH:D000544	1636

